Top VA biological product (except diagnostic) manufacturing contractors (NAICS 325414)
- Latest 12 months
- $5.2M
- Net obligations · Down $5.8M vs. $11.1M preceding
- Prime contractors
- 8
- With positive obligations in the latest 12 months
Research the VA federal contracting market for biological product (except diagnostic) manufacturing under NAICS 325414. Compare top federal contractors and market share, reported contract obligations and spending trends, funding-office attribution, recent award activity, and contract types, competition, and procurement methods.
Contract obligation trends for Biological Product (except Diagnostic) Manufacturing at the Department of Veterans Affairs
Federal records show $46.3M in net obligations across 174 awards in Biological Product (except Diagnostic) Manufacturing at the Department of Veterans Affairs from Oct 1, 2021 through Oct 23, 2026. This market accounts for 0.013% of $349.8B in agency-wide net prime contract obligations over the period shown. Latest 12-month net obligations decreased 52.7% from $11.1M to $5.2M. 3 prime contractors accounted for at least 80% of positive obligations in that latest period.
Fiscal-year activity
FY27 is year-to-date through Oct 23, 2026; earlier years show complete fiscal-year totals.
View fiscal-year data table
| Fiscal year | Net obligations | Contract actions | Coverage |
|---|---|---|---|
| FY2022 | $8.9M | 64 | Complete |
| FY2023 | $8.8M | 70 | Complete |
| FY2024 | $5.0M | 78 | Complete |
| FY2025 | $11.6M | 71 | Complete |
| FY2026 | $12.0M | 69 | Complete |
Market at a glance
All reported prime contract awards- All-period net obligations
- $46.3M
- 174 awards · 32 prime contractors
- Latest 12-month movement
- −52.7%
- $5.2M vs. $11.1M
- Leading eight prime share
- 100.0%
- Share held by the eight leading prime contractors in the latest 12 months
View agency share, denominators, and set-aside reporting
- Agency context
- 0.013% of $349.8B in agency-wide net obligations.
- Set-aside share when reported
- 0.0% of 46 awards with reported set-aside status.
- Set-aside reporting
- 0 set aside · 46 no set-aside · 128 not reported
What changed in the last 12 months?
Oct 24, 2025–Oct 23, 2026, compared with Oct 24, 2024–Oct 23, 2025.
Competitive shifts
AMERICAN NATIONAL RED CROSS, THE had the largest decline in reported obligations
Market structure
Top-five contractor share increased
How these findings are calculated
Findings are selected from matched-period changes in obligations, share, rank, funding offices, concentration, reported set-asides, material award actions, and agency-peer outliers. Related signals are combined, and only material evidence-backed changes are shown. Review the full methodology.
Federal contract obligations by funding office
See how positive obligations were attributed across funding offices in the 12 months ending Oct 23, 2026.
36.9% of positive obligations were attributed to 580-HOUSTON(00580). That represents $2.5M, up $455K from the preceding 12 months.
Latest 12-month share of positive obligations; the gray segment represents all other reported offices.
- 580-HOUSTON(00580)36.9% · $2.5M · up $455K
- 589 KAN WESTERN ORBIT27.9% · $1.9M · up $175K
- 598-NORTH LITTLE ROCK(00598)11.8% · $785K · up $167K
- 671-SAN ANTONIO (00671)11.2% · $743K · up $355K
- 586-JACKSON (00586)4.8% · $316K · down $59K
- All other reported offices7.5% of positive obligations
View reported office rankings, comparisons, and evidence
USAspending assigns each award to a funding office. That office may differ from the requiring activity, program office, contracting office, individual buyer, or actual customer.
Reported funding office
580-HOUSTON(00580)
#1Rank unchangedLatest 12 months
$2.5M
36.9% of positive obligations
Versus preceding 12 months
+$455K
1 active prime contractor · 2 awards
View office comparison and evidence
Reported obligations increased 22.7% from $2.0M to $2.5M. The office’s share of positive obligations moved from 17.4% to 36.9%, a change of +19.5 percentage points.
The latest period contains 2 actions across 2 awards. The preceding period contained 1 active prime contractor and 2 awards.
Reported funding office
589 KAN WESTERN ORBIT
#2Up 1 from #3Latest 12 months
$1.9M
27.9% of positive obligations
Versus preceding 12 months
+$175K
3 active prime contractors · 5 awards
View office comparison and evidence
Reported obligations increased 10.4% from $1.7M to $1.9M. The office’s share of positive obligations moved from 14.6% to 27.9%, a change of +13.3 percentage points.
The latest period contains 8 actions across 5 awards and 1 newly active prime contractor. The preceding period contained 2 active prime contractors and 4 awards.
Reported funding office
598-NORTH LITTLE ROCK(00598)
#3Up 3 from #6Latest 12 months
$785K
11.8% of positive obligations
Versus preceding 12 months
+$167K
1 active prime contractor · 2 awards
View office comparison and evidence
Reported obligations increased 27.1% from $618K to $785K. The office’s share of positive obligations moved from 5.4% to 11.8%, a change of +6.4 percentage points.
The latest period contains 3 actions across 2 awards. The preceding period contained 1 active prime contractor and 2 awards.
Reported funding office
671-SAN ANTONIO (00671)
#4Up 5 from #9Latest 12 months
$743K
11.2% of positive obligations
Versus preceding 12 months
+$355K
1 active prime contractor · 1 award
View office comparison and evidence
Reported obligations increased 91.6% from $388K to $743K. The office’s share of positive obligations moved from 3.4% to 11.2%, a change of +7.8 percentage points.
The latest period contains 1 action across 1 award. The preceding period contained 1 active prime contractor and 2 awards.
Reported funding office
586-JACKSON (00586)
#5Up 5 from #10Latest 12 months
$316K
4.8% of positive obligations
Versus preceding 12 months
−$59K
1 active prime contractor · 2 awards
View office comparison and evidence
Reported obligations decreased 15.7% from $375K to $316K. The office’s share of positive obligations moved from 3.3% to 4.8%, a change of +1.5 percentage points.
The latest period contains 2 actions across 2 awards. The preceding period contained 1 active prime contractor and 2 awards.
Reported funding office
578-HINES(00578)(36C578)
#6Up 1 from #7Latest 12 months
$223K
3.4% of positive obligations
Versus preceding 12 months
−$374K
2 active prime contractors · 5 awards
View office comparison and evidence
Reported obligations decreased 62.7% from $597K to $223K. The office’s share of positive obligations moved from 5.2% to 3.4%, a change of −1.9 percentage points.
The latest period contains 6 actions across 5 awards. The preceding period contained 2 active prime contractors and 5 awards.
Reported funding office
674-TEMPLE (00674)
#7New to the positive-obligation rankingLatest 12 months
$191K
2.9% of positive obligations
Versus preceding 12 months
+$474K
1 active prime contractor · 2 awards
View office comparison and evidence
Reported obligations moved from $284K in net deobligations to $191K in net obligations. The office’s share of positive obligations moved from 0% to 2.9%, a change of +2.9 percentage points.
The latest period contains 2 actions across 2 awards. The preceding period contained 1 active prime contractor and 1 award.
Leading award-level changes
- ROCHE DIAGNOSTICS CORPORATION · PIID 36C25726N0088+$488K: $0 → $488K
- ROCHE DIAGNOSTICS CORPORATION · PIID 36C25725N0039−$298K: $0 → −$298K
Reported funding office
541-BRECKSVILLE (00541)
#8Up 6 from #14Latest 12 months
$56K
0.85% of positive obligations
Versus preceding 12 months
−$120K
1 active prime contractor · 4 awards
View office comparison and evidence
Reported obligations decreased 68.1% from $177K to $56K. The office’s share of positive obligations moved from 1.5% to 0.85%, a change of −0.7 percentage points.
The latest period contains 4 actions across 4 awards. The preceding period contained 1 active prime contractor and 1 award.
Reported funding office
695-MILWAUKEE(00695)(36C695)
#9Down 4 from #5Latest 12 months
$28K
0.42% of positive obligations
Versus preceding 12 months
−$726K
1 active prime contractor · 1 award
View office comparison and evidence
Reported obligations decreased 96.3% from $754K to $28K. The office’s share of positive obligations moved from 6.6% to 0.42%, a change of −6.1 percentage points.
The latest period contains 1 action across 1 award. The preceding period contained 1 active prime contractor and 3 awards.
Reported funding office
607-MADISON(00607)(36C607)
No positive-obligation rankLatest 12 months
−$72K
0% of positive obligations
Versus preceding 12 months
−$580K
2 active prime contractors · 4 awards
View office comparison and evidence
Reported obligations moved from $508K in net obligations to $72K in net deobligations. The office’s share of positive obligations moved from 4.4% to 0%, a change of −4.4 percentage points.
The latest period contains 5 actions across 4 awards. The preceding period contained 2 active prime contractors and 6 awards.
Reported funding office
614-MEMPHIS(00614)
No positive-obligation rankLatest 12 months
−$194K
0% of positive obligations
Versus preceding 12 months
−$565K
1 active prime contractor · 2 awards
View office comparison and evidence
Reported obligations moved from $371K in net obligations to $194K in net deobligations. The office’s share of positive obligations moved from 3.2% to 0%, a change of −3.2 percentage points.
The latest period contains 2 actions across 2 awards. The preceding period contained 1 active prime contractor and 1 award.
Reported funding office
626-NASHVILLE (00626)
No positive-obligation rankLatest 12 months
−$364K
0% of positive obligations
Versus preceding 12 months
−$2.3M
1 active prime contractor · 1 award
View office comparison and evidence
Reported obligations moved from $1.9M in net obligations to $364K in net deobligations. The office’s share of positive obligations moved from 16.8% to 0%, a change of −16.8 percentage points.
The latest period contains 2 actions across 1 award. The preceding period contained 1 active prime contractor and 1 award.
Leading award-level changes
- AMERICAN NATIONAL RED CROSS, THE · PIID 36C24926N0108−$1.9M: $1.9M → $0
- AMERICAN NATIONAL RED CROSS, THE · PIID 36C24925N0117−$364K: $0 → −$364K
Reported funding office
618-MINNEAPOLIS VA MED CTR (00618)
No positive-obligation rankLatest 12 months
−$393K
0% of positive obligations
Versus preceding 12 months
−$1.5M
1 active prime contractor · 2 awards
View office comparison and evidence
Reported obligations moved from $1.1M in net obligations to $393K in net deobligations. The office’s share of positive obligations moved from 10.0% to 0%, a change of −10.0 percentage points.
The latest period contains 2 actions across 2 awards. The preceding period contained 1 active prime contractor and 2 awards.
Contract types, competition, and procurement methods
From Oct 24, 2025 through Oct 23, 2026, 18 awards had positive obligations totaling $9.1M. Negotiated Proposal/Quote was the leading reported procedure, accounting for 62.2% of positive obligations. Awards with a reported parent IDV accounted for 99.5%.
- Leading award type
- 99.5%
- Delivery Order
- Leading reported procedure
- 62.2%
- Negotiated Proposal/Quote
- Reported parent IDV
- 99.5%
- of positive obligations had a reported parent IDV
- Median reported offers
- 1
- 2 of 18 awards reported offers · Limited reporting
Buying method changes
Compared with Oct 24, 2024–Oct 23, 2025. Based on 18 current awards and 36 preceding awards with positive net obligations.
- Median positive award obligations
- $183K
- Up from $75K in the preceding period
How to read these changes
Directional color and the Up or Down labels show historical movement only. Green does not mean favorable and red does not mean unfavorable; neither predicts a future procurement method.
Same-NAICS comparison
Compared with the NAICS 325414 peer median, parent-IDV obligation share is 11.2 percentage points higher, reported full-and-open obligation share is 42.5 percentage points higher, delivery-order obligation share is 11.2 percentage points higher, and median positive award obligations are 227.3% higher.
| Measure | This market | Peer median | Difference |
|---|---|---|---|
| Parent-IDV obligation share | 99.5% | 88.3% | +11.2 pts |
| Reported full-and-open obligation share | 69.6% | 27.1% | +42.5 pts |
| Delivery-order obligation share | 99.5% | 88.3% | +11.2 pts |
| Median positive award obligations | $183K | $56K | +227.3% |
Peer cohort and comparison limits
The peer median gives each of the 3 eligible agency markets equal weight. The included agency markets are:
- Department of Agriculture (USDA)
- Department of Defense (DOD)
- Department of Health and Human Services (HHS)
Agency mission, scale, and acquisition context can differ. Peer position does not establish market attractiveness or predict a future procurement method.
View buying-method details and data coverage
Award types
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Delivery Order(C) | 17 | $9.1M | 99.5% |
| Purchase Order(B) | 1 | $48K | 0.52% |
Reported parent-award types
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| IDC(B) | 17 | $9.1M | 99.5% |
| Not reported | 1 | $48K | 0.52% |
Single- or multiple-award parent structure
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Single Award(S) | 16 | $8.4M | 92.1% |
| Multiple Award(M) | 1 | $670K | 7.3% |
| Not reported | 1 | $48K | 0.52% |
Solicitation procedures
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Negotiated Proposal/Quote(NP) | 4 | $5.7M | 62.2% |
| Np(NEGOTIATED PROPOSAL/QUOTE) | 5 | $1.0M | 11.0% |
| Only One Source(SSS) | 3 | $946K | 10.4% |
| Simplified Acquisition(SP1) | 3 | $714K | 7.8% |
| Subject to Multiple Award Fair Opportunity(MAFO) | 1 | $670K | 7.3% |
| Sp1(SIMPLIFIED ACQUISITION) | 1 | $60K | 0.66% |
| Other reported values | 1 | $48K | 0.52% |
Extent competed
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Full and Open Competition(A) | 5 | $6.3M | 69.6% |
| A(FULL AND OPEN COMPETITION) | 5 | $1.0M | 11.0% |
| Not Competed(C) | 2 | $927K | 10.2% |
| Not Competed Under SAP(G) | 2 | $489K | 5.4% |
| Competed Under SAP(F) | 1 | $225K | 2.5% |
| F(COMPETED UNDER SAP) | 1 | $60K | 0.66% |
| Other reported values | 2 | $67K | 0.74% |
Fair-opportunity and limited-source reporting
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Follow-on Action Following Competitive Initial Action(FOO) | 1 | $670K | 7.3% |
| Not reported | 17 | $8.4M | 92.7% |
Other-than-full-and-open reasons
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Only One Source-Other (FAR 6.302-1 Other)(ONE) | 3 | $974K | 10.7% |
| SAP Non-Competition (FAR 13)(SP2) | 2 | $489K | 5.4% |
| Authorized by Statute (FAR 6.302-5(A)(2)(I))(OTH) | 1 | $20K | 0.21% |
| Not reported | 12 | $7.6M | 83.7% |
Contract pricing types
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Firm Fixed Price(J) | 10 | $7.3M | 79.6% |
| J(FIRM FIXED PRICE) | 7 | $1.1M | 12.2% |
| Fixed Price with Economic Price Adjustment(K) | 1 | $743K | 8.2% |
Product or Service Codes
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Medical and Surgical Instruments, Equipment, and Supplies(6515) | 5 | $5.6M | 61.9% |
| Drugs and Biologicals(6505) | 10 | $2.9M | 32.0% |
| in Vitro Diagnostic Substances, Reagents, Test Kits and Sets(6550) | 1 | $488K | 5.4% |
| Laboratory Equipment and Supplies(6640) | 1 | $48K | 0.52% |
| Blood and Blood Products(6506) | 1 | $20K | 0.21% |
Awarding subagencies
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| Department of Veterans Affairs(3600) | 18 | $9.1M | 100.0% |
Awarding offices
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| 256-Network Contract Office 16 (36c256)(36C256) | 4 | $4.7M | 51.7% |
| 255-Network Contract Office 15 (36c255)(36C255) | 3 | $2.6M | 28.6% |
| 257-Network Contract Office 17 (36c257)(36C257) | 2 | $1.2M | 13.5% |
| 252-Network Contract Office 12 (36c252)(36C252) | 7 | $362K | 4.0% |
| 250-Network Contract Office 10 (36c250)(36C250) | 1 | $183K | 2.0% |
| 249-Network Contract Office 9 (36c249)(36C249) | 1 | $20K | 0.21% |
Reported parent IDVs
| Reported value | Awards | Positive obligations | Share |
|---|---|---|---|
| 36C25623D0030(3600) | 1 | $3.3M | 36.3% |
| 36C25522D0021(3600) | 1 | $1.9M | 20.7% |
| 36C25623D0017(3600) | 1 | $957K | 10.5% |
| 36C25722D0035(3600) | 1 | $743K | 8.2% |
| 36C25522D0022(3600) | 1 | $670K | 7.3% |
| 36C25724D0059(3600) | 1 | $488K | 5.4% |
| 36C25623D0057(3600) | 1 | $451K | 5.0% |
| 36C25221D0073(3600) | 2 | $285K | 3.1% |
| Other reported values | 8 | $280K | 3.1% |
| Not reported | 1 | $48K | 0.52% |
Offers, award size, and timing
- Median reported offers
- 1 median
- 2 reported · 16 not reported · Limited reporting
- Positive award obligations
- $183K median
- $20K–$670K middle 50%
- Reported performance period
- 364 days (~12 months) median
- 18 reported · 0 not reported
Calculations group latest-period actions by award, retain awards with positive net obligations for share denominators, and use each award's latest reported USAspending procurement fields as of Oct 23, 2026. Blank competition, pricing, PSC, or parent-IDV values remain not reported; they are not inferred. Offer counts must be positive and below the FPDS 999 placeholder. Awarding organizations can differ from the funding agency that defines this page.
Top federal contractors
Latest 12-month market share, concentration, and complete prime contractor rankings across the period shown.
- Prime contractor concentration
- 3 of 8prime contractors account for at least 80% of positive obligations in the last 12 months
- Largest prime contractor
- 54.1%of positive obligations in the last 12 months
- Leading four prime contractors
- 89.9%of positive obligations in the last 12 months
- Leading eight prime contractors
- 100.0%of positive obligations in the last 12 months
Based on $5.9M in positive obligations during the 12 months ending Oct 23, 2026. Individual shares and movement appear in the searchable rankings below. Movement compares with Oct 24, 2024–Oct 23, 2025.
Last 12mo obligation volume: Highest positive obligations first; net deobligations follow by magnitude; contractors with no activity in the last 12 months follow by all-period obligations. Ranks use the complete contractor list and remain fixed when search narrows the results.
- #1
Last 12mo obligations
$3.2M
54.1%
Dollar movement
−$1.4M
vs. prior 12 months
Last 12mo awards
21 awards
27 actions
Historical and award details for AMERICAN NATIONAL RED CROSS, THE
- Obligations: prior → latest
- $4.5M → $3.2M
- −30.0%
- Share: prior → latest
- 39.4% → 54.1%
- +14.7 percentage points
- All-period obligations
- $17.9M
- 38.6% of all-period positive obligations · 53 awards
- Recorded activity
- Since Oct 1, 2021
- through Oct 22, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 9 10 Not reported 12 10 Reported small business 0 0 All-period set-aside types
None reported.
- #2
Last 12mo obligations
$785K
13.4%
Dollar movement
+$167K
vs. prior 12 months
Last 12mo awards
2 awards
3 actions
Historical and award details for OKLAHOMA BLOOD INSTITUTE
- Obligations: prior → latest
- $618K → $785K
- +27.1%
- Share: prior → latest
- 5.4% → 13.4%
- +8.0 percentage points
- All-period obligations
- $2.5M
- 5.4% of all-period positive obligations · 8 awards
- Recorded activity
- Since Nov 10, 2021
- through Aug 24, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 0 0 Not reported 2 2 Reported small business 0 0 All-period set-aside types
None reported.
- #3
Last 12mo obligations
$743K
12.7%
Dollar movement
+$355K
vs. prior 12 months
Last 12mo awards
1 award
1 action
Historical and award details for SOUTH TEXAS BLOOD & TISSUE CENTER
- Obligations: prior → latest
- $388K → $743K
- +91.6%
- Share: prior → latest
- 3.4% → 12.7%
- +9.3 percentage points
- All-period obligations
- $2.1M
- 4.6% of all-period positive obligations · 8 awards
- Recorded activity
- Since Dec 17, 2021
- through Jan 29, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 0 0 Not reported 1 2 Reported small business 0 0 All-period set-aside types
None reported.
- #4
Last 12mo obligations
$566K
9.7%
Dollar movement
−$1K
vs. prior 12 months
Last 12mo awards
2 awards
3 actions
Historical and award details for NEW YORK BLOOD CENTER, INC.
- Obligations: prior → latest
- $568K → $566K
- −0.3%
- Share: prior → latest
- 4.9% → 9.7%
- +4.7 percentage points
- All-period obligations
- $3.1M
- 6.7% of all-period positive obligations · 10 awards
- Recorded activity
- Since Oct 1, 2021
- through Jul 14, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 0 0 Not reported 2 2 Reported small business 0 0 All-period set-aside types
None reported.
- #5
Last 12mo obligations
$316K
5.4%
Dollar movement
−$59K
vs. prior 12 months
Last 12mo awards
2 awards
2 actions
Historical and award details for MISSISSIPPI BLOOD SERVICES, INC.
- Obligations: prior → latest
- $375K → $316K
- −15.7%
- Share: prior → latest
- 3.3% → 5.4%
- +2.1 percentage points
- All-period obligations
- $1.0M
- 2.2% of all-period positive obligations · 7 awards
- Recorded activity
- Since Mar 25, 2022
- through Jun 24, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 0 0 Not reported 2 2 Reported small business 0 0 All-period set-aside types
None reported.
- #6
Last 12mo obligations
$170K
2.9%
Dollar movement
+$461K
vs. prior 12 months
Last 12mo awards
3 awards
3 actions
Historical and award details for ROCHE DIAGNOSTICS CORPORATION
- Obligations: prior → latest
- −$291K → $170K
- Not comparable
- Share: prior → latest
- 0% → 2.9%
- +2.9 percentage points
- All-period obligations
- $803K
- 1.7% of all-period positive obligations · 5 awards
- Recorded activity
- Since Oct 1, 2021
- through Jul 27, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 1 1 Not reported 2 1 Reported small business 0 0 All-period set-aside types
None reported.
- #7
Last 12mo obligations
$56K
0.96%
Dollar movement
−$120K
vs. prior 12 months
Last 12mo awards
4 awards
4 actions
Historical and award details for BINDING SITE, INC., THE
- Obligations: prior → latest
- $177K → $56K
- −68.1%
- Share: prior → latest
- 1.5% → 0.96%
- −0.6 percentage points
- All-period obligations
- $725K
- 1.6% of all-period positive obligations · 5 awards
- Recorded activity
- Since Feb 25, 2022
- through Mar 18, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 0 0 Not reported 4 1 Reported small business 4 1 All-period set-aside types
None reported.
- #8
Last 12mo obligations
$48K
0.81%
Dollar movement
+$48K
vs. prior 12 months
Last 12mo awards
1 award
1 action
Historical and award details for CELLULAR TECHNOLOGY LIMITED
- Obligations: prior → latest
- $0 → $48K
- Not comparable
- Share: prior → latest
- 0% → 0.81%
- +0.8 percentage points
- All-period obligations
- $48K
- 0.10% of all-period positive obligations · 1 award
- Recorded activity
- Since Jul 21, 2026
- through Jul 21, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 1 0 Not reported 0 0 Reported small business 1 0 All-period set-aside types
None reported.
- #9
Last 12mo obligations
−$364K
0%
Dollar movement
−$2.3M
vs. prior 12 months
Last 12mo awards
1 award
2 actions
Historical and award details for AMERICAN NATIONAL RED CROSS, THE
- Obligations: prior → latest
- $1.9M → −$364K
- Not comparable
- Share: prior → latest
- 16.8% → 0%
- −16.8 percentage points
- All-period obligations
- $3.4M
- 7.4% of all-period positive obligations · 2 awards
- Recorded activity
- Since Oct 1, 2024
- through Jul 1, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 0 0 Not reported 1 1 Reported small business 0 0 All-period set-aside types
None reported.
- #10
Last 12mo obligations
−$194K
0%
Dollar movement
−$565K
vs. prior 12 months
Last 12mo awards
2 awards
2 actions
Historical and award details for LIFESHARE BLOOD CENTER
- Obligations: prior → latest
- $371K → −$194K
- Not comparable
- Share: prior → latest
- 3.2% → 0%
- −3.2 percentage points
- All-period obligations
- $553K
- 1.2% of all-period positive obligations · 2 awards
- Recorded activity
- Since Oct 1, 2024
- through Jul 1, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 0 0 Not reported 2 1 Reported small business 0 0 All-period set-aside types
None reported.
- #11
Last 12mo obligations
−$24K
0%
Dollar movement
−$2.4M
vs. prior 12 months
Last 12mo awards
10 awards
10 actions
Historical and award details for VERSITI BLOOD HEALTH, INC.
- Obligations: prior → latest
- $2.4M → −$24K
- Not comparable
- Share: prior → latest
- 20.7% → 0%
- −20.7 percentage points
- All-period obligations
- $12.8M
- 27.6% of all-period positive obligations · 36 awards
- Recorded activity
- Since Oct 1, 2021
- through Sep 4, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 0 0 Not reported 10 17 Reported small business 0 0 All-period set-aside types
None reported.
- #12
Last 12mo obligations
−$16K
0%
Dollar movement
−$63K
vs. prior 12 months
Last 12mo awards
2 awards
2 actions
Historical and award details for COMMUNITY BLOOD CENTER OF THE OZARKS
- Obligations: prior → latest
- $47K → −$16K
- Not comparable
- Share: prior → latest
- 0.41% → 0%
- −0.4 percentage points
- All-period obligations
- $258K
- 0.56% of all-period positive obligations · 4 awards
- Recorded activity
- Since Dec 6, 2022
- through May 19, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 0 0 Not reported 2 2 Reported small business 0 0 All-period set-aside types
None reported.
- #13
Last 12mo obligations
−$8K
0%
Dollar movement
−$8K
vs. prior 12 months
Last 12mo awards
1 award
1 action
Historical and award details for EUROFINS GENOMICS BLUE HERON LLC
- Obligations: prior → latest
- $0 → −$8K
- Not comparable
- Share: prior → latest
- 0% → 0%
- 0.0 percentage points
- All-period obligations
- −$8K
- 0% of all-period positive obligations · 1 award
- Recorded activity
- Since Dec 18, 2025
- through Dec 18, 2025
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 1 0 Not reported 0 0 Reported small business 1 0 All-period set-aside types
None reported.
- #14
Last 12mo obligations
−$8K
0%
Dollar movement
−$66K
vs. prior 12 months
Last 12mo awards
1 award
1 action
Historical and award details for COMMUNITY BLOOD CENTER, INC.
- Obligations: prior → latest
- $58K → −$8K
- Not comparable
- Share: prior → latest
- 0.50% → 0%
- −0.5 percentage points
- All-period obligations
- $158K
- 0.34% of all-period positive obligations · 6 awards
- Recorded activity
- Since Oct 1, 2021
- through Jan 26, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 0 0 Not reported 1 4 Reported small business 0 0 All-period set-aside types
None reported.
- #15
Last 12mo obligations
−$6K
0%
Dollar movement
−$6K
vs. prior 12 months
Last 12mo awards
2 awards
2 actions
Historical and award details for IMPACTLIFE
- Obligations: prior → latest
- −$247 → −$6K
- Not comparable
- Share: prior → latest
- 0% → 0%
- 0.0 percentage points
- All-period obligations
- $13K
- 0.030% of all-period positive obligations · 5 awards
- Recorded activity
- Since Oct 1, 2021
- through Feb 19, 2026
Award reporting
Latest and prior 12-month award reporting Reported award evidence Latest Prior Reported set-aside 0 0 Reported no set-aside 0 0 Not reported 2 2 Reported small business 0 0 All-period set-aside types
None reported.
Recent federal contract award activity
Recent contract actions with unusually large obligation changes or meaningful shifts in contractor and funding-office activity.
This action
+$743K
SOUTH TEXAS BLOOD & TISSUE CENTER
671-SAN ANTONIO (00671)
BLOOD AND BLOOD PRODUCTS ORDERING PERIOD 5
Why it stands out
The contractor climbed 3 positions in this market.
It now ranks #3 by positive obligations over the latest 12 months.
- Award net obligations
- $743K
- Share of 12-month positive obligations
- 12.7%
Supporting data
- Prime contractor
- #3 · 12.7% share
- up 3 ranks · +9.3 percentage points · $355K net increase; action exceeded it by $388K
- Funding office
- #4 · 11.2% attributed share
- up 5 ranks · +7.8 percentage points · $355K net increase; action exceeded it by $388K
This action
+$488K
ROCHE DIAGNOSTICS CORPORATION
674-TEMPLE (00674)
CENTRAL TEXAS VA ROCHE VENTANA REAGENT
Why it stands out
One action represented 8.3% of the market’s latest 12-month positive obligations.
At $488K, the action was large enough to materially affect the latest 12-month market picture.
- Award net obligations
- $488K
- Share of 12-month positive obligations
- 8.3%
Supporting data
- Prime contractor
- #6 · 2.9% share
- +2.9 percentage points · $461K net increase; action exceeded it by $27K
- Funding office
- #7 · 2.9% attributed share
- +2.9 percentage points · $474K net increase; action exceeded it by $14K
This action
+$3.3M
AMERICAN NATIONAL RED CROSS, THE
580-HOUSTON(00580)
BLOOD AND BLOOD PRODUCT IN SUPPORT OF MEDVAMC - ORDERING PERIOD 4
Why it stands out
One action equaled at least half of the market’s latest 12-month positive obligations.
The $3.3M action represented 56.5% of the market’s positive obligations over the latest 12 months.
- Award net obligations
- $3.3M
- Share of 12-month positive obligations
- 56.5%
Supporting data
- Prime contractor
- #1 · 54.1% share
- $1.4M net decline despite this positive action
- Funding office
- #1 · 36.9% attributed share
- +19.5 percentage points · $455K net increase; action exceeded it by $2.9M
This action
+$1.1M
OKLAHOMA BLOOD INSTITUTE
598-NORTH LITTLE ROCK(00598)
BLOOD PRODUCTS AND TESTING SERVICES - EXERCISE OPTION PERIOD 3
Why it stands out
The contractor climbed 2 positions in this market.
It now ranks #2 by positive obligations over the latest 12 months.
- Award net obligations
- $957K
- Share of 12-month positive obligations
- 18.1%
Supporting data
- Prime contractor
- #2 · 13.4% share
- up 2 ranks · +8.0 percentage points · $167K net increase; action exceeded it by $889K
This action
+$670K
NEW YORK BLOOD CENTER, INC.
589 KAN WESTERN ORBIT
BLOOD, BLOOD PRODUCTS AND RELATED SERVICES
Why it stands out
A new award added obligations despite weaker contractor activity.
The action represented 11.4% of the market’s latest 12-month positive obligations while the contractor’s obligations fell $1K overall.
- Award net obligations
- $670K
- Share of 12-month positive obligations
- 11.4%
Supporting data
- Prime contractor
- #4 · 9.7% share
- $1K net decline despite this positive action
This action
+$451K
MISSISSIPPI BLOOD SERVICES, INC.
586-JACKSON (00586)
BLOOD AND BLOOD PRODUCTS
Why it stands out
A new award added obligations despite weaker contractor activity.
The action represented 7.7% of the market’s latest 12-month positive obligations while the contractor’s obligations fell $59K overall.
- Award net obligations
- $451K
- Share of 12-month positive obligations
- 7.7%
Supporting data
- Prime contractor
- #5 · 5.4% share
- $59K net decline despite this positive action
- Funding office
- #5 · 4.8% attributed share
- $59K net decline despite this positive action
View recent award activity by date (10)
- Action−$3KAward net obligations$0
- Action−$2KAward net obligations$0
- Action−$170Award net obligations$0
- Action−$10KAward net obligations$0
- Action−$37KAward net obligations$3K
- Action−$2KAward net obligations$0
- Action−$2KAward net obligations$0
- Action+$40KAward net obligations$40K
- Action+$5KAward net obligations$5K
- Action+$3KAward net obligations$3K
VA biological product (except diagnostic) manufacturing market FAQs
Answers based on reported federal contract data.
Who are the top VA biological product (except diagnostic) manufacturing contractors?
In the 12 months through October 23, 2026, AMERICAN NATIONAL RED CROSS, THE, OKLAHOMA BLOOD INSTITUTE, and SOUTH TEXAS BLOOD & TISSUE CENTER were the leading VA biological product (except diagnostic) manufacturing prime contractors by positive obligations.
- #1
AMERICAN NATIONAL RED CROSS, THE
$3,170,572 in positive obligations
- #2
$785,045 in positive obligations
- #3
SOUTH TEXAS BLOOD & TISSUE CENTER
$743,203 in positive obligations
Rankings use reported USAspending award data.
Did VA contract obligations decrease in the biological product (except diagnostic) manufacturing market?
Yes. Measured by net prime contract obligations, reported VA activity in the biological product (except diagnostic) manufacturing market decreased 52.7% from $11,065,617 in the preceding 12 months to $5,233,839 in the 12 months through October 23, 2026.
- Latest 12 months
- $5,233,839
- Net prime contract obligations
- Preceding 12 months
- $11,065,617
- Net prime contract obligations
- Change
- −52.7%
- Between matched 12-month periods
Reported contract actions, not outlays or a forecast.
What recent VA contract award activity was reported in the biological product (except diagnostic) manufacturing market?
Recent VA contract award activity reported in the biological product (except diagnostic) manufacturing market included actions for SOUTH TEXAS BLOOD & TISSUE CENTER, ROCHE DIAGNOSTICS CORPORATION, and AMERICAN NATIONAL RED CROSS, THE during the 12 months through October 23, 2026.
-
SOUTH TEXAS BLOOD & TISSUE CENTER · PIID 36C25726N0185
Base award · January 29, 2026 · Action obligation: +$743,203
-
ROCHE DIAGNOSTICS CORPORATION · PIID 36C25726N0088
Base award · December 18, 2025 · Action obligation: +$488,480
-
AMERICAN NATIONAL RED CROSS, THE · PIID 36C25626N0272
Base award · November 28, 2025 · Action obligation: +$3,307,829
-
OKLAHOMA BLOOD INSTITUTE · PIID 36C25626N0271
Base award · November 26, 2025 · Action obligation: +$1,056,691
-
NEW YORK BLOOD CENTER, INC. · PIID 36C25526N0171
Base award · March 18, 2026 · Action obligation: +$670,000
-
MISSISSIPPI BLOOD SERVICES, INC. · PIID 36C25626N0431
Base award · March 11, 2026 · Action obligation: +$451,164
Action obligations are transaction-level amounts, not current award-level obligations.
Which procurement methods were reported for VA contracts under NAICS 325414?
From October 24, 2025 through October 23, 2026, VA reported 18 positive-obligation awards for biological product (except diagnostic) manufacturing under NAICS 325414. The leading award type was delivery order. The leading reported procedure was negotiated proposal/quote.
- Positive-obligation awards
- 18
- Leading reported procedure
- Negotiated Proposal/Quote
- 62.2% of positive obligations
- Leading award type
- Delivery Order
- 99.5% of positive obligations
- Full and open
- 69.6%
- of positive obligations
- Reported parent IDV
- 99.5%
- of positive obligations
Percentages use positive obligations as the denominator.
Apply this research to a live pursuit
Sweetspot connects opportunity qualification, competitive research, capture, and proposal work in one workspace.
Related market research
Complete market indexes:
Same NAICS at other agencies:
Nearby NAICS at this agency:
Markets sharing leading prime records:
Reported obligations include contract actions from October 1, 2021 through October 23, 2026. Set-aside and business-size fields reflect award records, not a contractor's current eligibility.
Review data methodology